Literature DB >> 8650478

Natural history of chronic Chagas' heart disease: prognosis factors.

C Mady1, R Nacruth.   

Abstract

Chronic Chagas' disease shows several progression modes. Usually, the different clinical syndromes manifest themselves together, however, isolated forms can occur. Cardiac arrhythmias, which are very frequent, are present in about 50% of patients. The cardiac damage manifests itself later, with the emergence of heart failure. Thromboembolism can occur in both pulmonary and systemic circulation. Pulmonary embolism is the most frequent, appearing in more advanced phases of heart disease. Sudden death is the fatal outcome of these patients. It predominates in males and generally occurs in a disease stage when patients have their highest productivity. The presence of serious ventricular arrhythmias, conduction disturbances in the electrocardiogram, and heart failure, provide an unfavorable prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 8650478     DOI: 10.1590/s1516-31801995000200009

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  4 in total

1.  Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial.

Authors:  Gilberto M Sperandio da Silva; Mayara C Chambela; Andrea S Sousa; Luiz Henrique C Sangenis; Sergio S Xavier; Andréa R Costa; Pedro Emmanuel A A Brasil; Alejandro M Hasslocher-Moreno; Roberto M Saraiva
Journal:  Trials       Date:  2012-12-27       Impact factor: 2.279

2.  Prevalence of Chagas Disease in a U.S. Population of Latin American Immigrants with Conduction Abnormalities on Electrocardiogram.

Authors:  Mahmoud I Traina; Salvador Hernandez; Daniel R Sanchez; Jalal Dufani; Mohsin Salih; Adieb M Abuhamidah; Wilman Olmedo; Jason S Bradfield; Colin J Forsyth; Sheba K Meymandi
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

3.  Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial.

Authors:  Paula S Silva; Gilberto Marcelo Sperandio da Silva; Andréa P de Souza; Claudia S A Cardoso; Cristiane A Fonseca; Patricia D Brito; Roberto M Saraiva; Pedro E A Brasil; Roberta O Pinheiro; Alejandro M Hasslocher-Moreno; Sérgio S Xavier; Andréa S Sousa
Journal:  Trials       Date:  2013-11-11       Impact factor: 2.279

4.  Electrophysiological characteristics of Chagas disease.

Authors:  Swellen Schuenemann Cedraz; Paulo Christo Coutinho da Silva; Ricardo Katsumi Yendo Minowa; Juliano Furtado de Aragão; Danilo Victor Silva; Carlos Morillo; Dalmo Antonio Ribeiro Moreira; Ricardo Garbe Habib; Bruno Pereira Valdigem; Luciana Vidal Armaganijan
Journal:  Einstein (Sao Paulo)       Date:  2013 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.